Global L-Histidine Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Product Type;
Tablet, Capsule, Fluids, and OthersBy Grade;
Pharmaceutical Grade, Food Grade, Feed GradeBy Source;
Fermentation-Based L-Histidine, Synthetic L-HistidineBy Application;
Pharmaceutical Industry, Biotechnological Industry, and Medical IndustryBy Distribution Channel;
Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and OthersBy End-Users;
Hospitals, Specialty Clinics, Ambulatory Surgical Centres, and OthersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)L-Histidine Market Overview
L-Histidine Market (USD Million)
L-Histidine Market was valued at USD 709.93 million in the year 2024. The size of this market is expected to increase to USD 1,137.68 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 7.0%.
Global L-Histidine Market Growth, Share, Size, Trends and Forecast
*Market size in USD million
CAGR 7.0 %
Study Period | 2025 - 2031 |
---|---|
Base Year | 2024 |
CAGR (%) | 7.0 % |
Market Size (2024) | USD 709.93 Million |
Market Size (2031) | USD 1,137.68 Million |
Market Concentration | Medium |
Report Pages | 377 |
Major Players
- Angene Chemicals
- Abi Chemicals
- Acron Pharma
- Ajimomoto
- Changzhou Highassay Chemical Co. Ltd
- Huaheng Biologgical
- My Protein
- Twin Labs
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Global L-Histidine Market
Fragmented - Highly competitive market without dominant players
Rising Utilization in Pharmaceutical and Biotech Industries
The pharmaceutical and biotechnology sectors continue to significantly influence the market trajectory of L-histidine. Its utility in intravenous therapies, buffer solutions for biologics, and metabolic treatments has amplified its demand. Presently, pharmaceutical applications comprise around 35% of the global market share, driven by the compound’s versatility in drug formulations and disease management. Its use is further reinforced by ongoing medical research and its proven therapeutic efficacy.
Increased Demand from Sports Nutrition and Functional Foods
With health and wellness becoming top priorities for consumers, L-histidine is gaining momentum in sports nutrition and functional food segments. Known for aiding in muscle repair and reducing exercise-induced fatigue, it has become a popular inclusion in performance supplements. This niche is expanding at an annual growth rate of approximately 12%, reflecting a clear shift towards amino acid-based recovery and endurance products aimed at active lifestyles.
Innovation in Manufacturing Technologies
Technological progress in fermentation and amino acid production has played a crucial role in market expansion. Modern extraction and bioengineering techniques have enhanced both the efficiency and sustainability of L-histidine manufacturing. Notably, close to 40% of producers are transitioning to eco-friendly biotechnological methods, addressing growing consumer interest in natural and clean-label ingredients while also lowering production costs.
Supportive Research and Regulatory Developments
The favorable research landscape and regulatory support further strengthen the growth outlook for L-histidine. Emerging studies are investigating its potential benefits in neurological health, inflammation control, and metabolic disorders. With over 25% of nutritional clinical trials involving amino acid analysis, L-histidine continues to capture scientific and commercial interest. These combined factors are fostering a robust and optimistic market environment for the foreseeable future.
L-Histidine Market Recent Developments
-
In 2023, Ajinomoto Co., Inc., a global leader in the amino acid industry, expanded its L-Histidine production facilities to meet rising demand.This move addressed growing use in pharmaceuticals, nutritional supplements, and food additives, enhancing supply of high-purity L-Histidine and strengthening its global market position.
-
In January 2022, research reaffirmed that histidine, a vital amino acid, is indispensable for both infants and adults. Recognized for its involvement in protein biosynthesis and supporting immune function, histidine is encoded by the genetic codons CAU and CAC. Its physiological importance stems from its role in enzyme activity and cellular repair processes. This amino acid was first identified and isolated in 1896 by renowned scientists Albrecht Kossel and Sven Hedin, marking a foundational moment in amino acid research.
L-Histidine Market Segment Analysis
In this report, the L-Histidine Market has been segmented by Product Type, Grade, Source, Application, Distribution Channel, End Users, and Geography.
L-Histidine Market, Segmentation by Product Type
The L-Histidine Market has been segmented by Product Type into Tablet, Capsule, Fluids, and Others.
Tablets
The tablet form of L-Histidine dominates the market, accounting for approximately 40% of the total market share. This format is preferred due to its convenience, portability, and precise dosage control, making it a popular choice among consumers seeking health supplements for immune support and muscle recovery. Tablets also offer easy incorporation into daily routines, contributing to their sustained market presence. This segment is expected to maintain steady growth driven by the increasing demand for convenient nutritional products.
Capsules
Following closely behind, capsules represent 35% of the L-Histidine market. Capsules are highly valued for their rapid absorption and easy-to-consume nature. This product form is particularly popular among health-conscious individuals and athletes who prioritize quick results. The increasing availability of vegan and vegetarian capsules has further boosted their appeal, attracting a broader audience. With the rising popularity of dietary supplements, the capsule segment is projected to experience consistent growth.
Fluids
While the fluids segment currently holds a smaller share at around 15%, it is experiencing rapid growth. Fluids are highly sought after due to their quick absorption and are often used in clinical settings or by athletes who require immediate energy boosts. Additionally, liquid forms are ideal for individuals who have difficulty swallowing pills. As the demand for liquid supplements rises, this segment is anticipated to witness significant expansion in the near future.
Other Forms
The other category, which includes products like powders and gels, contributes approximately 10% to the market. These alternatives are gaining traction for their flexibility and ability to be tailored to individual needs. With a growing emphasis on personalized nutrition and sports nutrition, the "Others" segment is expected to grow steadily, offering a range of options that cater to specific consumer preferences.
L-Histidine Market, Segmentation by Grade
The L-Histidine Market has been segmented by Grade Type into Pharmaceutical Grade, Food Grade, Feed Grade.
Pharmaceutical Grade
The pharmaceutical grade L-Histidine dominates the market, accounting for approximately 50% of the total market share. It is a crucial component in the development of medications and nutritional supplements that are used to treat a variety of health conditions, including immune system disorders and joint health issues. The increasing prevalence of chronic diseases and the growing demand for health supplements are expected to drive continuous growth in this segment.
Food Grade
The food grade L-Histidine segment represents about 30% of the market. It is commonly used in the food industry to enhance the nutritional content and flavor of processed foods. With rising consumer interest in functional foods and nutrient-dense beverages, the demand for food-grade L-Histidine is expected to increase. This form of L-Histidine is increasingly incorporated into dietary supplements, fortified foods, and drinks designed to improve overall health.
Feed Grade
The feed grade L-Histidine, while making up about 20% of the market, plays a vital role in animal nutrition. It is essential for enhancing the growth and productivity of livestock by ensuring proper amino acid balance in animal feed. As the global demand for animal products continues to rise, the feed-grade segment is expected to grow, driven by the increasing need for efficient animal farming and sustainable practices.
L-Histidine Market, Segmentation by Source
The L-Histidine Market has been segmented by Source into Fermentation-Based L-Histidine, Synthetic L-Histidine.
Fermentation-Based L-Histidine
Fermentation-based L-Histidine dominates the global market, representing approximately 60% of the total share. This production method is highly regarded for its natural and eco-friendly approach, making it the preferred choice in sectors where product purity and sustainability are crucial. The ability to scale production efficiently while maintaining high quality makes fermentation-based L-Histidine ideal for the pharmaceutical and biotech industries. As the global focus on environmentally conscious manufacturing grows, the demand for fermentation-based L-Histidine is set to rise.
Synthetic L-Histidine
On the other hand, synthetic L-Histidine comprises about 40% of the market. The synthetic process involves the chemical creation of L-Histidine, which is often more cost-effective for mass production. While not typically used for high-purity pharmaceutical applications, synthetic L-Histidine remains a dominant choice in sectors like animal feed and food production, where cost is a primary consideration. Despite its lower purity, synthetic L-Histidine plays a vital role in meeting the demand for affordable products across various industries.
L-Histidine Market, Segmentation by Application
The L-Histidine Market has been segmented by Application into Pharmaceutical Industry, Biotechnological Industry, and Medical Industry.
Pharmaceutical Industry
The pharmaceutical industry holds the largest share in the L-Histidine market, accounting for approximately 50% of the overall market. L-Histidine is used extensively in the development of medications and nutritional supplements, particularly for immune system support, joint health, and cognitive function. This segment’s dominance is driven by the increasing prevalence of chronic diseases and the growing demand for therapeutic supplements. The pharmaceutical industry's continuous expansion, along with the rising focus on personalized medicine, ensures that L-Histidine will remain a critical ingredient in drug formulations.
Biotechnological Industry
The biotechnological industry is another significant application area, contributing approximately 30% to the L-Histidine market. L-Histidine is essential in bioprocesses, including the production of biologicals, biosimilars, and vaccines. It is a key component in the cultivation of microbial cultures used for creating essential medicines like antibodies and enzymes. With advancements in genetic engineering, biotechnology is experiencing rapid growth, and this is expected to further drive the demand for L-Histidine in this sector.
Medical Industry
While the medical industry holds a smaller share of around 20%, it plays an important role in the utilization of L-Histidine. In medical settings, L-Histidine is used in IV treatments and as part of parenteral nutrition, particularly for patients who cannot take nutrients orally. As healthcare infrastructure grows and medical treatments become more specialized, the use of L-Histidine in the medical industry is projected to increase, enhancing its value in clinical nutrition and hospital care.
L-Histidine Market, Segmentation by Distribution Channel
The L-Histidine Market has been segmented by Distribution Channel into Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Others.
Direct Tender
The direct tender segment dominates the market, accounting for approximately 40% of the total share. This channel is primarily used by large institutions, including governments and pharmaceutical companies, to procure bulk quantities of L-Histidine. The ability to negotiate favorable prices for large orders makes the direct tender distribution model a cost-effective solution for healthcare institutions. As healthcare infrastructure grows worldwide, particularly in emerging economies, the direct tender segment is expected to maintain its leading position.
Hospital Pharmacy
The hospital pharmacy segment contributes about 25% to the L-Histidine market. Hospitals rely on pharmacies to provide essential L-Histidine-based products to patients undergoing treatments, especially for nutritional support and immune system enhancement. As healthcare systems expand and more hospitals adopt advanced care practices, the demand for L-Histidine through hospital pharmacies is expected to rise steadily, particularly in developing regions with expanding healthcare infrastructure.
Retail Pharmacy
The retail pharmacy segment represents 20% of the market share. This channel serves individual consumers seeking L-Histidine for general health and wellness purposes, such as immune support and joint health. Retail pharmacies are becoming increasingly popular for stocking L-Histidine-based products, driven by rising consumer interest in dietary supplements and preventative healthcare. The convenience and accessibility of retail pharmacies continue to drive the growth of this distribution channel.
Online Pharmacy
The online pharmacy segment is growing rapidly, making up around 10% of the L-Histidine market. As e-commerce continues to expand, consumers are increasingly turning to online pharmacies for the convenience of home delivery and a wider product selection. Online pharmacies provide an easy and accessible way for consumers to purchase L-Histidine-based products, especially among tech-savvy younger populations. The growth of online pharmacy platforms is expected to continue as consumer preferences shift toward digital shopping.
Others
The others category, comprising about 5% of the market, includes alternative retail channels such as health food stores and direct-to-consumer platforms. While this segment is smaller, it holds potential for future growth as more consumers explore non-traditional retail avenues for health supplements. As awareness of L-Histidine’s benefits continues to rise, these alternative distribution channels are expected to play an increasingly important role in the market.
L-Histidine Market, Segmentation by End Users
The L-Histidine Market has been segmented by End Users into Hospitals, Specialty Clinics, Ambulatory Surgical Centres, and Others.
Hospitals
The hospitals segment leads the L-Histidine market, accounting for approximately 40% of the market share. Hospitals rely heavily on L-Histidine for a variety of therapeutic purposes, such as supporting patient recovery, immune function, and nutritional support during critical treatments. The growing prevalence of chronic illnesses, along with the rising aging population, ensures that the demand for L-Histidine in hospitals will continue to rise, making this the largest market segment.
Specialty Clinics
Specialty clinics contribute about 30% to the L-Histidine market. These clinics utilize L-Histidine for specialized treatments, particularly in areas such as muscle recovery, joint health, and autoimmune diseases. With the increasing focus on personalized care and more niche therapeutic solutions, the demand for L-Histidine in specialty clinics is expected to grow, driven by the rising adoption of advanced healthcare practices.
Ambulatory Surgical Centers
Ambulatory surgical centers (ASCs) account for around 20% of the L-Histidine market. These centres often use L-Histidine to support post-surgical recovery, especially in patients receiving intravenous nutrition. With the growing preference for outpatient surgeries due to cost savings and quicker recovery times, the use of L-Histidine in ASCs is projected to increase. This segment is expected to experience steady growth as ASCs continue to gain popularity.
Other
The others segment, which includes home healthcare services and rehabilitation centers, makes up about 10% of the market. This segment sees the use of L-Histidine to support general health, immune function, and muscle recovery in non-hospital settings. As the demand for home healthcare and alternative therapies continues to rise, the L-Histidine market in this category is expected to grow.
L-Histidine Market, Segmentation by Geography
In this report, the L-Histidine Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Regions and Countries Analyzed in this Report
L-Histidine Market Share (%), by Geographical Region, 2024
North America
North America is the largest market for L-Histidine, holding approximately 40% of the global share. The region’s demand is largely driven by high rates of chronic diseases and a strong preference for nutritional supplements and immune health products. The presence of advanced healthcare systems, increasing health awareness, and growing consumer interest in preventive healthcare are some of the key factors propelling market growth in North America. The pharmaceutical and biotech sectors are also major contributors to the region’s dominant position.
Europe
Europe accounts for around 30% of the L-Histidine market. The region's demand for L-Histidine is supported by an aging population, an increase in health-conscious consumers, and the growing need for immune support and nutritional products. With a robust healthcare infrastructure and a rising interest in personalized health solutions, Europe continues to witness steady market growth. The increasing demand for L-Histidine-based products in retail pharmacies and specialized clinics is also contributing to the region’s market growth.
Asia Pacific
The Asia Pacific region is seeing the fastest growth in the L-Histidine market, contributing about 20% to the global share. The rise in disposable income, healthcare accessibility, and awareness of nutritional products are the key drivers behind the market's rapid expansion. Countries like China, India, and Japan are witnessing a surge in L-Histidine demand due to rising healthcare needs and the adoption of preventive healthcare practices. As the region continues to expand its healthcare infrastructure, Asia Pacific is expected to experience substantial growth in the coming years.
Middle East and Africa
The Middle East and Africa region holds a smaller share of around 5%, but it is experiencing steady growth. The increasing investments in healthcare infrastructure, along with rising demand for nutritional supplements, are boosting the demand for L-Histidine in this region. Countries such as the UAE and South Africa are leading the growth, with the pharmaceutical and health food sectors seeing an uptick in the use of L-Histidine-based products. As the region’s healthcare market continues to evolve, this segment is expected to show gradual growth.
Latin America
Latin America accounts for about 5% of the L-Histidine market. Despite its smaller share, the market in this region is expanding due to a growing middle class and increased healthcare investments. Countries like Brazil and Mexico are driving demand for L-Histidine, especially in nutritional supplements and health-focused products. As healthcare accessibility improves and retail pharmacies expand, the L-Histidine market in Latin America is expected to grow, albeit at a slower pace compared to other regions.
L-Histidine Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of L-Histidine Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Comprehensive Market Impact Matrix
This matrix outlines how core market forces—Drivers, Restraints, and Opportunities—affect key business dimensions including Growth, Competition, Customer Behavior, Regulation, and Innovation.
Market Forces ↓ / Impact Areas → | Market Growth Rate | Competitive Landscape | Customer Behavior | Regulatory Influence | Innovation Potential |
---|---|---|---|---|---|
Drivers | High impact (e.g., tech adoption, rising demand) | Encourages new entrants and fosters expansion | Increases usage and enhances demand elasticity | Often aligns with progressive policy trends | Fuels R&D initiatives and product development |
Restraints | Slows growth (e.g., high costs, supply chain issues) | Raises entry barriers and may drive market consolidation | Deters consumption due to friction or low awareness | Introduces compliance hurdles and regulatory risks | Limits innovation appetite and risk tolerance |
Opportunities | Unlocks new segments or untapped geographies | Creates white space for innovation and M&A | Opens new use cases and shifts consumer preferences | Policy shifts may offer strategic advantages | Sparks disruptive innovation and strategic alliances |
Drivers, Restraints and Opportunity Analysis
Drivers:
- Rising demand in pharmaceutical formulations
- Increasing use in dietary supplements industry
- Growing application in animal feed nutrition
-
Expanding role in metabolic disorder treatments - The growing application of L-Histidine in metabolic disorder treatment is a key driver accelerating the expansion of the L-Histidine market. As medical research continues to highlight the importance of amino acids in managing chronic health conditions, L-Histidine is receiving increased attention for its role in vital metabolic processes. It supports protein synthesis, enzyme function, neurotransmitter activity, and nitrogen balance, making it an essential nutrient for addressing issues linked to obesity, diabetes, and metabolic syndrome.
Emerging clinical data also emphasizes L-Histidine’s antioxidant and anti-inflammatory properties, which are critical in mitigating oxidative stress and cellular damage common in metabolic diseases. Furthermore, L-Histidine plays a role in enhancing glucose metabolism and improving insulin sensitivity, which positions it as a promising ingredient in dietary supplements and pharmaceutical products designed to improve metabolic health. This growing recognition is fueling its adoption in nutraceuticals, functional foods, and therapeutic applications.
Restraints:
- High production and purification costs
- Limited raw material availability globally
- Stringent regulations on amino acid usage
-
Low consumer awareness in developing regions - One of the key challenges impacting the growth of the L-Histidine market is the low consumer awareness in developing regions. While L-Histidine has been recognized for its numerous therapeutic and health benefits in developed markets, its adoption remains limited in many emerging economies. This gap in awareness is primarily due to a lack of public education and insufficient promotion of amino acid-based supplements and functional ingredients within these regions' healthcare systems.
In many developing countries, healthcare priorities often focus on basic nutrition, managing communicable diseases, and access to essential medicines. As a result, products like L-Histidine, which are related to dietary supplements and amino acid therapies, are sometimes perceived as non-essential or luxury items. This issue is compounded by a lack of accessible, reliable information about the role of amino acids in treating conditions such as metabolic disorders, neurological issues, and other chronic health problems.
The absence of strong distribution networks and low engagement from key market players in rural or underdeveloped areas restrict the availability of L-Histidine-based products. The lack of marketing efforts by nutraceutical and pharmaceutical companies contributes to the limited familiarity of healthcare professionals and consumers with the benefits and applications of L-Histidine. Even where such products are available, concerns about their affordability and perceived efficacy persist.
To overcome this barrier, companies must focus on raising awareness, educating healthcare professionals, and forming local partnerships to improve both knowledge and access to L-Histidine products. Without addressing these challenges and fostering trust in its health benefits, the market will continue to experience slow growth, especially in regions that represent a large portion of the global population.
Opportunities:
- Advances in fermentation-based production methods
- Expansion into functional food and beverages
- Rising R&D in amino acid therapies
-
Growth potential in emerging healthcare markets - The L-Histidine market holds substantial growth potential in emerging healthcare markets as awareness of nutritional supplements and functional foods continues to increase. As healthcare systems in developing economies evolve, there is a growing emphasis on preventive health and wellness, creating an opportunity for products like L-Histidine. Recognized for its diverse benefits, such as supporting metabolic health, boosting immunity, and enhancing cognitive function, L-Histidine is gaining attention in regions focused on improving overall well-being.
The rise in lifestyle-related diseases in emerging markets is contributing to the demand for alternative healthcare solutions. As chronic conditions such as diabetes, obesity, and cardiovascular diseases become more prevalent, L-Histidine is being recognized as a natural adjunct to conventional pharmaceutical treatments. Its ability to regulate glucose metabolism, promote detoxification, and support metabolic balance positions it as a promising option for both consumers and healthcare professionals seeking preventive healthcare alternatives.
The expanding middle class in emerging economies presents a valuable opportunity for the L-Histidine market. With increasing disposable incomes, more individuals are investing in their health and wellness. This growing demand for high-quality, bioavailable ingredients like L-Histidine drives the market for dietary supplements and functional foods. The trend toward holistic health and personalized medicine further enhances L-Histidine’s appeal as a critical component in addressing both individual and public health needs.
The growth of e-commerce platforms and the enhancement of distribution channels are making it easier for L-Histidine products to reach a wider audience. As availability increases and awareness grows, the L-Histidine market is poised to expand rapidly, leveraging the untapped potential of emerging healthcare markets to drive product adoption and foster sustained market growth.
L-Histidine Market Competitive Landscape Analysis
Key players in L-Histidine Market include:
- Angene Chemicals
- Abi Chemicals
- Acron Pharma
- Ajinomoto Co. Inc.
- Changzhou Highassay Chemical Co. Ltd.
- Huaheng Biologgical
- Kyowa Hakko Bio Co. Ltd.
- My Protein
- Twin Labs
- Merck & Co. Inc.
- Novartis AG
- Hoffmann-La Roche Ltd
- Amgen Inc
- Eisai Co. Ltd.
- GlaxoSmithKline plc.
- Pfizer Inc
- Nordisk A/S
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Market Share Analysis
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Grade
- Market Snapshot, By Source
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By End Users
- Market Snapshot, By Region
- L-Histidine Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Rising demand in pharmaceutical formulations
- Increasing use in dietary supplements industry
- Growing application in animal feed nutrition
- Expanding role in metabolic disorder treatments
- Restraints
- High production and purification costs
- Limited raw material availability globally
- Stringent regulations on amino acid usage
- Low consumer awareness in developing regions
- Opportunities
- Advances in fermentation-based production methods
- Expansion into functional food and beverages
- Rising R&D in amino acid therapies
- Growth potential in emerging healthcare markets
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- L-Histidine Market, By Product Type, 2021 - 2031 (USD Million)
- Tablet
- Capsule
- Fluids
- Others
- L-Histidine Market, By Grade, 2021 - 2031 (USD Million)
- Pharmaceutical Grade
- Food Grade
- Feed Grade
- L-Histidine Market, By Source, 2021 - 2031 (USD Million)
- Fermentation-Based L-Histidine
- Synthetic L-Histidine
-
L-Histidine Market, By Application, 2021 - 2031 (USD Million)
-
Pharmaceutical Industry
-
Biotechnological Industry
-
Medical Industry
-
- L-Histidine Market, By Distribution Channel, 2021 - 2031 (USD Million)
- Direct Tender
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
-
L-Histidine Market, By End Users, 2021 - 2031 (USD Million)
-
Hospitals
-
Specialty Clinics
-
Ambulatory Surgical Centres
-
Other
-
- L-Histidine Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- L-Histidine Market, By Product Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Angene Chemicals
- Abi Chemicals
- Acron Pharma
- Ajinomoto Co. Inc.
- Changzhou Highassay Chemical Co. Ltd.
- Huaheng Biologgical
- Kyowa Hakko Bio Co. Ltd.
- My Protein
- Twin Labs
- Merck & Co. Inc.
- Novartis AG
- Hoffmann-La Roche Ltd
- Amgen Inc
- Eisai Co. Ltd.
- GlaxoSmithKline plc.
- Pfizer Inc
- Nordisk A/S
- Company Profiles
- Analyst Views
- Future Outlook of the Market